Coeliac Disease and Mast Cells
AbstractOver the last decades, there has been an impressive progress in our understanding of coeliac disease pathogenesis and it has become clear that the disorder is the final result of complex interactions of environmental, genetic, and immunological factors. Coeliac disease is now considered a prototype of T-cell-mediated disease characterized by loss of tolerance to dietary gluten and the targeted killing of enterocytes by T-cell receptor αβ intraepithelial lymphocytes. Accumulating evidence, however, indicates that the induction of a gluten-specific T helper-1 response must be preceded by the activation of the innate immune system. Mast cells are key players of the innate immune response and contribute to the pathogenesis of a multitude of diseases. Here, we review the results of studies aimed at investigating the role of mast cells in the pathogenesis of coeliac disease, showing that these cells increase in number during the progression of the disease and contribute to define a pro-inflammatory microenvironment. View Full-Text
Share & Cite This Article
Frossi, B.; De Carli, M.; Calabrò, A. Coeliac Disease and Mast Cells. Int. J. Mol. Sci. 2019, 20, 3400.
Frossi B, De Carli M, Calabrò A. Coeliac Disease and Mast Cells. International Journal of Molecular Sciences. 2019; 20(14):3400.Chicago/Turabian Style
Frossi, Barbara; De Carli, Marco; Calabrò, Antonino. 2019. "Coeliac Disease and Mast Cells." Int. J. Mol. Sci. 20, no. 14: 3400.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.